Medivie Therapeutic is an Israeli public company, which developed Laboraide – a breakthrough technology that helps women to relieve stress and migraines during childbirth, without medicines. Laboraide is a birth bite that can alleviate the pain of women in labor and increase the blood flow to the muscles, resulting in reduced risks of surgical intervention during childbirth. These technologies are anchored in international patents and constitute the company’s intellectual property.
In 2017, the Company changed hands and the new owners decided to step-up and enter the pharma arena through Hi-Pharma – Medivie’s private daughter company, which focuses on the field of growing cannabis plants, with emphasis on Medical Cannabis (MC), and manufacturing premium MC products.
Growing Cannabis is not the goal, but the means.
In Medivie we believe that in order to become a pivotal player in the medical cannabis market in Israel and world-wide, we need to constantly innovate and create differentiation when developing pharma products from medical cannabis, as well as high-quality and unique extraction oils and flora.
We advocate collaborations in the areas of research, science, agriculture, medicine, pharma and novel technologies, together with business and strategic partnerships and technological alliances, with companies in Israel and worldwide.
Hi-Pharma is the private daughter company of Medivie, focusing on Medical Cannabis and located up-north Israel.
The Hi-Pharma team brings over 30 years of experience in the arenas of cultivation fields and manufacturing products of Medical Cannabis, in Europe and USA.
Hi-Pharma operates according to the new standards of the Ministry of Health, and the IMC – Israeli Medical Cannabis Association.
The Company is establishing agricultural farms for medical cannabis, with Indoor and Outdoor greenhouses according to the IMC-GAP regulations.
Adjacent to the farm, Hi-Pharma is setting-up a professional and well-equipped factory to produce a variety of unique state-of-the-art medical cannabis products, which are aimed at the pharma and clinic industries, according to the IMC-GMP regulations.
Hi-Pharma is one of the largest medical cannabis companies in Israel, it owns about 50 acres of agricultural land in a kibbutz in the north of the country, a production plant of about 1,000 sqm. and a highly experienced staff in the fields of cannabis, botany, agriculture, pharma, clinics and biotechnology, Marketing and BD.
Hi-Pharma is one of the few companies that holds most of the licenses of the medical cannabis industry.